IMMUNOLOGIC, GENETIC AND EXPOSURE-RELATED PATHWAYS TO CHILDHOOD ASTHMA
IMMUNOLOGIC, GENETIC AND EXPOSURE-RELATED PATHWAYS TO CHILDHOOD ASTHMA
批准号:
8030420
负责人:
Anne L. Wright
金额:
$69.93万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-01-01 至 2013-02-28
关键词:
10 year oldAgeAirAllergensAsthmaBirthBlood specimenCanis familiarisCell physiologyCharacteristicsChildChildhoodChildhood AsthmaChronic DiseaseComplexDay CareDevelopmentDiseaseEnvironmentEnvironmental Risk FactorExhalationExposure toFoodGenesGeneticGenetic VariationHealthHypersensitivityIgEImmuneImmune responseImmune systemImmunologicsInfantInhalant dose formInterleukin-10LifeLinkMeasurementMitogensNatural ImmunityNitric OxideOutcomePathway interactionsPatternPhenotypePlant RootsPopulationPredispositionPrevalencePreventionPrevention strategyProductionPublic HealthQuestionnairesRegulatory T-LymphocyteResearchRespiratory physiologyRiskRoleRouteSymptomsSystems DevelopmentTimeVariantWheezingairway inflammationatopyclinically relevantcohortcytokinedesignearly childhoodearly life exposuregene environment interactionimprovedmonocytenovel strategiesprotective effectrespiratoryresponseskin prick test
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Asthma, the most common chronic disease of childhood in the US, originates in part in altered immune system development in early childhood. Both genetic and environmental factors influence asthma risk, and recent research suggests that the effect of particular gene variants on asthma risk may only be expressed in particular environments. Thus, the objective of this competitive renewal is to assess, prospectively, the roles of early life exposures, variation in innate immunity genes, immune system maturation, and their interactions on the development of asthma related phenotypes (i.e. persistent wheeze, bronchial responsiveness [BR] and lung function alterations) in childhood. Specific aims of the project are to: 1) Assess the influence of interactions between early life exposures and innate immunity gene variants on asthma-like symptoms, airway inflammation, BR and lung function in the first decade of life; 2) Establish the relation between patterns of maturation of adaptive immune responses in early life and the development of persistent wheeze and lung function alterations at age 8; and 3) Determine the roles of IL-10 production, T regulatory cells, and monocytes in regulating development of immune responses early in life and in influencing susceptibility to asthma-related phenotypes. The proposed project will utilize an existing birth cohort of almost 500 children, the Infant Immune Study. When these children are 6-10 years old, we will assess baseline lung function, BR using cold dry air, and airway inflammation using exhaled nitric oxide; and obtain allergy skin prick tests, blood samples for cellular studies and IgE, and a questionnaire. These functional measurements of asthma status will be assessed for relation with a) interactions between common early life exposures, assessed prospectively, with innate immunity gene variants, b) characteristic patterns of immune system maturation in the first 5 years of life, and c) the development of T regulatory cell function. We propose a novel approach to identifying which components of complex exposures may be relevant to their protective effect against asthma, by identifying genetic modifiers of these relations. These studies, which have not yet been accomplished in a non-selected population followed from birth, will contribute substantially to our understanding of the relation of innate, regulatory, and adaptive immune responses over time to the subsequent development of asthma related outcomes, holding promise for the design of prevention strategies for this common and complex disease.
The objective of this project is to assess the roles of early life exposures, variation in innate immunity genes, immune system maturation, and their interactions on the development of asthma-related outcomes in childhood. The project will be conducted in a birth cohort of almost 500 children, the Infant Immune Study, whose immune system development and respiratory health has been extensively characterized in the first 5 years of life. The study will advance our understanding of the relation of immune responses over time to the subsequent development of asthma and lung function alterations, and will thereby contribute to the design of appropriate prevention strategies for this common and complex disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Recruitment, Data Collection & Sample Management Core
-
批准号:10088088
-
项目类别:
-
资助金额:$137.84万
-
财政年份:2020
-
负责人:Anne L. Wright
-
依托单位:
Recruitment, Data Collection & Sample Management Core
-
批准号:10457918
-
项目类别:
-
资助金额:$70.9万
-
财政年份:2020
-
负责人:Anne L. Wright
-
依托单位:
Recruitment, Data Collection & Sample Management Core
-
批准号:10652404
-
项目类别:
-
资助金额:$29.42万
-
财政年份:2020
-
负责人:Anne L. Wright
-
依托单位:
Recruitment, Data Collection & Sample Management Core
-
批准号:10214520
-
项目类别:
-
资助金额:$68.96万
-
财政年份:2020
-
负责人:Anne L. Wright
-
依托单位:
CONFERENCE: STUDY OF HUMAN MILK AND LACTATION
-
批准号:6158351
-
项目类别:
-
资助金额:$2.4万
-
财政年份:2000
-
负责人:Anne L. Wright
-
依托单位:
Immunologic Pathways to Childhood Asthma
-
批准号:7008858
-
项目类别:
-
资助金额:$63.53万
-
财政年份:1998
-
负责人:Anne L. Wright
-
依托单位:
IMMUNOLOGIC, GENETIC AND EXPOSURE-RELATED PATHWAYS TO CHILDHOOD ASTHMA
-
批准号:7571564
-
项目类别:
-
资助金额:$72.75万
-
财政年份:1998
-
负责人:Anne L. Wright
-
依托单位:
MATERNAL INFLUENCES ON CHILDHOOD ASTHMA
-
批准号:2454484
-
项目类别:
-
资助金额:$46.8万
-
财政年份:1998
-
负责人:Anne L. Wright
-
依托单位:
MATERNAL INFLUENCES ON CHILDHOOD ASTHMA
-
批准号:6488695
-
项目类别:
-
资助金额:$45.71万
-
财政年份:1998
-
负责人:Anne L. Wright
-
依托单位:
IMMUNOLOGIC, GENETIC AND EXPOSURE-RELATED PATHWAYS TO CHILDHOOD ASTHMA
-
批准号:7364940
-
项目类别:
-
资助金额:$72.05万
-
财政年份:1998
-
负责人:Anne L. Wright
-
依托单位:
IMMUNOLOGIC, GENETIC AND EXPOSURE-RELATED PATHWAYS TO CHILDHOOD ASTHMA
-
批准号:8225377
-
项目类别:
-
资助金额:$69.69万
-
财政年份:1998
-
负责人:Anne L. Wright
-
依托单位:
Immunologic Pathways to Childhood Asthma
-
批准号:6894182
-
项目类别:
-
资助金额:$3.6万
-
财政年份:1998
-
负责人:Anne L. Wright
-
依托单位:
Immunologic Pathways to Childhood Asthma
-
批准号:6694791
-
项目类别:
-
资助金额:$56.95万
-
财政年份:1998
-
负责人:Anne L. Wright
-
依托单位:
IMMUNOLOGIC, GENETIC AND EXPOSURE-RELATED PATHWAYS TO CHILDHOOD ASTHMA
-
批准号:7766232
-
项目类别:
-
资助金额:$72.07万
-
财政年份:1998
-
负责人:Anne L. Wright
-
依托单位:
MATERNAL INFLUENCES ON CHILDHOOD ASTHMA
-
批准号:6137239
-
项目类别:
-
资助金额:$54.75万
-
财政年份:1998
-
负责人:Anne L. Wright
-
依托单位:
Immunologic Pathways to Childhood Asthma
-
批准号:7169899
-
项目类别:
-
资助金额:$60.82万
-
财政年份:1998
-
负责人:Anne L. Wright
-
依托单位:
Immunologic Pathways to Childhood Asthma
-
批准号:6838736
-
项目类别:
-
资助金额:$65.31万
-
财政年份:1998
-
负责人:Anne L. Wright
-
依托单位:
MATERNAL INFLUENCES ON CHILDHOOD ASTHMA
-
批准号:6341689
-
项目类别:
-
资助金额:$46.16万
-
财政年份:1998
-
负责人:Anne L. Wright
-
依托单位:
Immunologic Pathways to Childhood Asthma
-
批准号:6576747
-
项目类别:
-
资助金额:$54.33万
-
财政年份:1998
-
负责人:Anne L. Wright
-
依托单位:
MATERNAL INFLUENCES ON CHILDHOOD ASTHMA
-
批准号:2856086
-
项目类别:
-
资助金额:$48.94万
-
财政年份:1998
-
负责人:Anne L. Wright
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: